Immunobiology of Plasmodium in liver and brain

Parasite Immunology

Volumn 35, Issue 9-10, 2013, Pages 267-282

  Frevert, U ^a   Nacer, A ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT PASTEUR   (France)

Author keywords

Blood brain barrier; Intravital imaging; Liver; Malaria; Post capillary venule; Sequestration

Indexed keywords

ANGIOPOIETIN 1; BRADYKININ; CD31 ANTIGEN; FINGOLIMOD; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; SPHINGOSINE 1 PHOSPHATE; THROMBIN; THROMBOCYTE FACTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADAPTIVE IMMUNITY; ARTICLE; BLOOD BRAIN BARRIER; BLOOD RHEOLOGY; BRAIN DISEASE; BRAIN MALARIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELLULAR IMMUNITY; COLLAPSE; COMPUTER ASSISTED TOMOGRAPHY; CONFOCAL MICROSCOPY; CYTOTOXICITY; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HYPERTENSION ENCEPHALOPATHY; IMMUNE RESPONSE; IMMUNOBIOLOGY; KUPFFER CELL; LIVER CELL; MEMORY T LYMPHOCYTE; MICROENVIRONMENT; MICROVASCULATURE; MORBIDITY; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITE CLEARANCE; PARASITE VIRULENCE; PATHOGENESIS; PLACENTA MALARIA; PLASMODIUM; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; PRIORITY JOURNAL; TROPHOZOITE; VASOCONSTRICTION;

BLOOD-BRAIN BARRIER; INTRAVITAL IMAGING; LIVER; MALARIA; POST-CAPILLARY VENULE; SEQUESTRATION;

ANIMALS; HOST-PARASITE INTERACTIONS; HUMANS; LIVER DISEASES; LYMPHOCYTES; MALARIA, CEREBRAL; PLASMODIUM; VACCINATION;

EID: 84881517585     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12039     Document Type: Article

References (195)

1. WHO. WHO Global Malaria Programme. Geneva, Switzerland, World Health Organization, 2011.
2. Milner DA Jr. Rethinking cerebral malaria pathology. Curr Opin Infect Dis 2010; 23: 456-463.
3. Vanderberg JP & Frevert U. Intravital microscopy demonstrating antibody-mediated immobilization of Plasmodium berghei sporozoites injected into skin by mosquitoes. Int J Parasitol 2004; 34: 991-996.
4. Frischknecht F, Baldacci P, Martin B, et al. Imaging movement of malaria parasites during transmission by Anopheles mosquitoes. Cell Microbiol 2004; 6: 687-694.
5. Gueirard P, Tavares J, Thiberge S, et al. Development of the malaria parasite in the skin of the mammalian host. Proc Natl Acad Sci USA 2010; 107: 18640-18645.
6. Amino R, Thiberge S, Martin B, et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat Med 2006; 12: 220-224.
7. Frevert U, Engelmann S, Zougbédé S, et al. Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol 2005; 3: e192.
8. Baer K, Roosevelt M, Van Rooijen N, Clarkson AB Jr, Schnieder T & Frevert U. Kupffer cells are obligatory for Plasmodium sporozoite infection of the liver. Cell Microbiol 2007; 9: 397-412.
9. Ishino T, Yano K, Chinzei Y & Yuda M. Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol 2004; 2: E4.
10. White NJ & Imwong M. Relapse. Adv Parasitol 2012; 80: 113-150.
11. Voorberg-van der Wel A, Zeeman AM, van Amsterdam SM, et al. Transgenic fluorescent Plasmodium cynomolgi liver stages enable live imaging and purification of Malaria hypnozoite-forms. PLoS ONE 2013; 8: e54888.
12. Rankin KE, Graewe S, Heussler VT & Stanway RR. Imaging liver-stage malaria parasites. Cell Microbiol 2010; 12: 569-579.
13. Baer K, Klotz C, Kappe SHIK, Schnieder T & Frevert U. Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 2007; 3: e171.
14. Sturm A, Amino R, van de Sand C, et al. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 2006; 313: 1287-1290.
15. Haldar K, Murphy SC, Milner DA & Taylor TE. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol 2007; 2: 217-249.
16. Bannister L & Mitchell G. The ins, outs and roundabouts of malaria. Trends Parasitol 2003; 19: 209-213.
17. Bannister LH, Hopkins JM, Fowler RE, Krishna S & Mitchell GH. A brief illustrated guide to the ultrastructure of Plasmodium falciparum asexual blood stages. Parasitol Today 2000; 16: 427-433.
18. Goldberg DE & Cowman AF. Moving in and renovating: exporting proteins from Plasmodium into host erythrocytes. Nat Rev Microbiol 2010; 8: 617-621.
19. Hanssen E, Carlton P, Deed S, et al. Whole cell imaging reveals novel modular features of the exomembrane system of the malaria parasite, Plasmodium falciparum. Int J Parasitol 2010; 40: 123-134.
20. Hanssen E, Goldie KN & Tilley L. Ultrastructure of the asexual blood stages of Plasmodium falciparum. Methods Cell Biol 2010; 96: 93-116.
21. Hanssen E, McMillan PJ & Tilley L. Cellular architecture of Plasmodium falciparum-infected erythrocytes. Int J Parasitol 2010; 40: 1127-1135.
22. Cyrklaff M, Sanchez CP, Kilian N, et al. Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes. Science 2011; 334: 1283-1286.
23. Scherf A, Lopez-Rubio JJ & Riviere L. Antigenic variation in Plasmodium falciparum. Annu Rev Microbiol 2008; 62: 445-470.
24. Tilley L, McFadden G, Cowman A & Klonis N. Illuminating Plasmodium falciparum-infected red blood cells. Trends Parasitol 2007; 23: 268-277.
25. Tilley L, Sougrat R, Lithgow T & Hanssen E. The twists and turns of Maurer's cleft trafficking in P. falciparum-infected erythrocytes. Traffic 2008; 9: 187-197.
26. Rogerson SJ, Grau GE & Hunt NH. The microcirculation in severe malaria. Microcirculation 2004; 11: 559-576.
27. Avril M, Tripathi AK, Brazier AJ, et al. A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells. Proc Natl Acad Sci USA 2012; 109: E1782-E1790.
28. Salanti A, Staalsoe T, Lavstsen T, et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003; 49: 179-191.
29. Fried M & Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996; 272: 1502-1504.
30. Maier AG, Cooke BM, Cowman AF & Tilley L. Malaria parasite proteins that remodel the host erythrocyte. Nat Rev Microbiol 2009; 7: 341-354.
31. van der Heyde HC, Nolan J, Combes V, Gramaglia I & Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol 2006; 22: 503-508.
32. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1): S1-S90.
33. Idro R, Marsh K, John CC & Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res 2010; 68: 267-274.
34. Postels DG, Chimalizeni YF, Mallewa M, Boivin MJ & Seydel KB. Pediatric cerebral malaria: a scourge of Africa. Future Neurol 2013; 8: 67-85.
35. Birbeck GL, Molyneux ME, Kaplan PW, et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol 2010; 9: 1173-1181.
36. Fried M, Muehlenbachs A & Duffy PE. Diagnosing malaria in pregnancy: an update. Expert Rev Anti Infect Ther 2012; 10: 1177-1187.
37. de Moraes LV, Tadokoro CE, Gomez-Conde I, Olivieri DN & Penha-Goncalves C. Intravital placenta imaging reveals microcirculatory dynamics impact on sequestration and phagocytosis of Plasmodium-infected erythrocytes. PLoS Pathog 2013; 9: e1003154.
38. Linares M, Marin-Garcia P, Perez-Benavente S, et al. Brain-derived neurotrophic factor and the course of experimental cerebral malaria. Brain Res 2013; 1490: 210-224.
39. Clark IA, Cowden WB & Rockett KA. The pathogenesis of human cerebral malaria. Parasitol Today 1994; 10: 417-418.
40. Clark IA, Jacobson LS & Rockett KA. Acidosis in severe childhood malaria. QJM 1997; 90: 601-604.
41. Clark IA & Rockett KA. The cytokine theory of human cerebral malaria. Parasitol Today 1994; 10: 410-412.
42. Franke-Fayard B, Fonager J, Braks A, Khan SM & Janse CJ. Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria? PLoS Pathog 2010; 6: e1001032.
43. Kim H, Higgins S, Liles WC & Kain KC. Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr Opin Hematol 2011; 18: 177-185.
44. Lomar AV, Vidal JE, Lomar FP, Barbas CV, de Matos GJ & Boulos M. Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz J Infect Dis 2005; 9: 425-430.
45. Bertolino P, McCaughan GW & Bowen DG. Role of primary intrahepatic T-cell activation in the 'liver tolerance effect'. Immunol Cell Biol 2002; 80: 84-92.
46. Crispe IN. The liver as a lymphoid organ. Annu Rev Immunol 2009; 27: 147-163.
47. Knolle PA & Limmer A. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol 2001; 22: 432-437.
48. Mackay IR. Hepatoimmunology: a perspective. Immunol Cell Biol 2002; 80: 36-44.
49. Racanelli V & Rehermann B. The liver as an immunological organ. Hepatology 2006; 43: S54-S62.
50. Sheth K & Bankey P. The liver as an immune organ. Curr Opin Crit Care 2001; 7: 99-104.
51. Ohtani O & Ohtani Y. Lymph circulation in the liver. Anat Rec (Hoboken) 2008; 291: 643-652.
52. Henriksen JH, Horn T & Christoffersen P. The blood-lymph barrier in the liver. A review based on morphological and functional concepts of normal and cirrhotic liver. Liver 1984; 4: 221-232.
53. Trutmann M & Sasse D. The lymphatics of the liver. Anat Embryol (Berl) 1994; 190: 201-209.
54. Tsuji M. A retrospective evaluation of the role of T cells in the development of malaria vaccine. Exp Parasitol 2010; 126: 421-425.
55. Overstreet MG, Cockburn IA, Chen YC & Zavala F. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol Rev 2008; 225: 272-283.
56. Doolan DL & Martinez-Alier N. Immune response to pre-erythrocytic stages of malaria parasites. Curr Mol Med 2006; 6: 169-185.
57. Krzych U & Schwenk J. The dissection of CD8 T cells during liver-stage infection. Curr Top Microbiol Immunol 2005; 297: 1-24.
58. Frevert U & Nardin E. Cellular effector mechanisms against Plasmodium liver stages. Cell Microbiol 2008; 10: 1956-1967.
59. Bongfen SE, Torgler R, Romero JF, Renia L & Corradin G. Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro. J Immunol 2007; 178: 7054-7063.
60. Rénia L, Marussig MS, Grillot D, et al. In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sci USA 1991; 88: 7963-7967.
61. Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH & Wang R. Genetically attenated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. J Immunol 2009; 183: 5870-5878.
62. Warren A, Le Couteur DG, Fraser R, Bowen DG, McCaughan GW & Bertolino P. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 2006; 44: 1182-1190.
63. Chakravarty S, Cockburn IA, Kuk S, Overstreet MG, Sacci JB & Zavala F. CD8(+) T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat Med 2007; 13: 1035-1041.
64. Balam S, Romero JF, Bongfen SE, Guillaume P & Corradin G. CSP-A model for in vivo presentation of Plasmodium berghei sporozoite antigens by hepatocytes. PLoS ONE 2012; 7: e51875.
65. Doolan DL & Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol 2000; 165: 1453-1492.
66. Mall FP. On the origin of the lymphatics in the liver. Johns Hopkins Hospital Bull 1901; XII: 121-123.
67. Magari S. Hepatic lymphatic system: structure and function. J Gastroenterol Hepatol 1990; 5: 82-93.
68. Reid LM, Fiorino AS, Sigal SH, Brill S & Holst PA. Extracellular matrix gradients in the space of Disse: relevance to liver biology. Hepatology 1992; 15: 1198-1203.
69. Heath T & Lowden S. Pathways of interstitial fluid and lymph flow in the liver acinus of the sheep and mouse. J Anat 1998; 192(Pt 3): 351-358.
70. Schatzki PF. Electron microscopy of lymphatics of the porta hepatitis. Acta Anat (Basel) 1978; 102: 54-59.
71. Matsuno K, Miyakawa K, Ezaki T & Kotani M. The liver lymphatics as a migratory pathway of macrophages from the sinusoids to the celiac lymph nodes in the rat. Arch Histol Cytol 1990; 53(Suppl): 179-187.
72. Arimoto J, Ikura Y, Suekane T, et al. Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers. J Gastroenterol 2010; 45: 317-325.
73. Mouta Carreira C, Nasser SM, di Tomaso E, et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 2001; 61: 8079-8084.
74. Le Couteur DG, Fraser R, Hilmer S, Rivory LP & McLean AJ. The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 2005; 44: 187-200.
75. Popescu D, Movileanu L, Ion S & Flonta ML. Hydrodynamic effects on the solute transport across endothelial pores and hepatocyte membranes. Phys Med Biol 2000; 45: N157-N165.
76. Chakravarty S, Baldeviano GC, Overstreet MG & Zavala F. Effector CD8+ T lymphocytes against malaria liver stages do not require IFN-{gamma} for anti-parasite activity. Infect Immun 2008; 76: 3628-3631.
77. Butler NS, Schmidt NW & Harty JT. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J Immunol 2010; 184: 2528-2538.
78. Belnoue E, Costa FT, Frankenberg T, et al. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 2004; 172: 2487-2495.
79. Epstein JE, Tewari K, Lyke KE, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8 T cell immunity. Science 2011; 334: 475-480.
80. Frevert U, Moreno A, Calvo Calle JM, Klotz C & Nardin E. Imaging human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein. Int J Parasitol 2008; 39: 119-132.
81. Greenway CV & Lautt WW. Effects of hepatic venous pressure on transsinusoidal fluid transfer in the liver of the anesthetized cat. Circ Res 1970; 26: 697-703.
82. Laine GA, Hall JT, Laine SH & Granger J. Transsinusoidal fluid dynamics in canine liver during venous hypertension. Circ Res 1979; 45: 317-323.
83. Wisse E, De Zanger RB, Jacobs R & McCuskey RS. Scanning electron microscope observations on the structure of portal veins, sinusoids and central veins in rat liver. Scan Electron Microsc 1983; 1441-1452.
84. Cabrera M & Frevert U. Novel in vivo imaging techniques for the liver microvasculature. IntraVital 2012; 1: 107-114.
85. Clark IA, Alleva LM, Budd AC & Cowden WB. Understanding the role of inflammatory cytokines in malaria and related diseases. Travel Med Infect Dis 2008; 6: 67-81.
86. Clark IA, Budd AC, Alleva LM & Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar J 2006; 5: 85.
87. Schofield L & Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005; 5: 722-735.
88. Dondorp AM, Ince C, Charunwatthana P, et al. Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis 2008; 197: 79-84.
89. Siegenthaler N, Giraud R & Bendjelid K. Erythrocytapheresis and sublingual micro-vascular flow in severe malaria. Clin Hemorheol Microcirc 2010; 46: 299-304.
90. Potchen MJ, Birbeck GL, Demarco JK, et al. Neuroimaging findings in children with retinopathy-confirmed cerebral malaria. Eur J Radiol 2010; 74: 262-268.
91. Postels DG, Taylor TE, Molyneux M, et al. Neurologic outcomes in retinopathy-negative cerebral malaria survivors. Neurology 2012; 79: 1268-1272.
92. White VA, Lewallen S, Beare NA, Molyneux ME & Taylor TE. Retinal pathology of pediatric cerebral malaria in Malawi. PLoS ONE 2009; 4: e4317.
93. Postels DG & Birbeck GL. Children with retinopathy-negative cerebral malaria: a pathophysiologic puzzle. Pediatr Infect Dis J 2011; 30: 953-956.
94. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S & Warrell DA. Human cerebral malaria a quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 1985; 119: 385-401.
95. Marchiafava E & Bignami A. On Summer-Autumn Malarial Fevers. London, The New Sydenham Society, 1894.
96. Clark IA & Rockett KA. Sequestration, cytokines, and malaria pathology. Int J Parasitol 1994; 24: 165-166.
97. Clark IA, Rockett KA & Cowden WB. Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol Today 1991; 7: 205-207.
98. Clark IA, Rockett RA & Cowden WB. TNF in cerebral malaria. Q J Med 1993; 86: 217-218.
99. Clark IA, Virelizier JL, Carswell EA & Wood PR. Possible importance of macrophage-derived mediators in acute malaria. Infect Immun 1981; 32: 1058-1066.
100. Craig AG, Khairul MF & Patil PR. Cytoadherence and severe malaria. Malays J Med Sci 2012; 19: 5-18.
101. Newton CR, Taylor TE & Whitten RO. Pathophysiology of fatal falciparum malaria in African children. Am J Trop Med Hyg 1998; 58: 673-683.
102. Grau GE, Mackenzie CD, Carr RA, et al. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis 2003; 187: 461-466.
103. Brown H, Rogerson S, Taylor T, et al. Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg 2001; 64: 207-213.
104. Buffet PA, Safeukui I, Milon G, Mercereau-Puijalon O & David PH. Retention of erythrocytes in the spleen: a double-edged process in human malaria. Curr Opin Hematol 2009; 16: 157-164.
105. Faille D, El-Assaad F, Alessi MC, Fusai T, Combes V & Grau GE. Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost 2009; 102: 1093-1102.
106. Wassmer SC, Lepolard C, Traore B, Pouvelle B, Gysin J & Grau GE. Platelets reorient Plasmodium falciparum-infected erythrocyte cytoadhesion to activated endothelial cells. J Infect Dis 2004; 189: 180-189.
107. Bridges DJ, Bunn J, van Mourik JA, et al. Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood 2010; 115: 1472-1474.
108. Larkin D, de Laat B, Jenkins PV, et al. Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog 2009; 5: e1000349.
109. Love MS, Millholland MG, Mishra S, et al. Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials. Cell Host Microbe 2012; 12: 815-823.
110. McMorran BJ, Wieczorski L, Drysdale KE, et al. Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum. Science 2012; 338: 1348-1351.
111. Polack B, Peyron F, Sheick Zadiuddin I, Kolodie L & Ambroise-Thomas P. [Erythrocytes infected by Plasmodium falciparum activate human platelets]. C R Acad Sci III 1990; 310: 577-582.
112. McMorran BJ, Marshall VM, de Graaf C, et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 2009; 323: 797-800.
113. Carvalho BO, Lopes SCP, Nogueira PA, et al. On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis 2010; 202: 638-647.
114. Fatih FA, Siner A, Ahmed A, et al. Cytoadherence and virulence - the case of Plasmodium knowlesi malaria. Malar J 2012; 11: 33.
115. Howard RJ, Barnwell JW & Kao V. Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes. Proc Natl Acad Sci USA 1983; 80: 4129-4133.
116. Al-Khedery B, Barnwell JW & Galinski MR. Antigenic variation in malaria: a 3′ genomic alteration associated with the expression of a P. knowlesi variant antigen. Mol Cell 1999; 3: 131-141.
117. Korir CC & Galinski MR. Proteomic studies of Plasmodium knowlesi SICA variant antigens demonstrate their relationship with P. falciparum EMP1. Infect Genet Evol 2006; 6: 75-79.
118. Bernabeu M, Lopez FJ, Ferrer M, et al. Functional analysis of Plasmodium vivax VIR proteins reveals different subcellular localizations and cytoadherence to the ICAM-1 endothelial receptor. Cell Microbiol 2012; 14: 386-400.
119. Lacerda MV, Fragoso SC, Alecrim MG, et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis 2012; 55: e67-e74.
120. Manning L, Rosanas-Urgell A, Laman M, et al. A histopathologic study of fatal paediatric cerebral malaria caused by mixed Plasmodium falciparum/Plasmodium vivax infections. Malar J 2012; 11: 107.
121. Manning L, Laman M, Law I, et al. Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS ONE 2011; 6: e29203.
122. Cox-Singh J, Hiu J, Lucas SB, et al. Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings: a case report. Malar J 2010; 9: 10.
123. Handayani S, Chiu DT, Tjitra E, et al. High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. J Infect Dis 2009; 199: 445-450.
124. Nacer A, Movila A, Baer K, Mikolajczak SA, Kappe SH & Frevert U. Neuroimmunological blood brain barrier opening in experimental cerebral malaria. PLoS Pathog 2012; 8: e1002982.
125. Brewster DR, Kwiatkowski D & White NJ. Neurological sequelae of cerebral malaria in children. Lancet 1990; 336: 1039-1043.
126. White NJ & Ho M. The pathophysiology of malaria. Adv Parasitol 1992; 31: 83-173.
127. White NJ, Turner GDH, Medana IM, Dondorp AM & Day NPJ. The murine cerebral malaria phenomenon. Trends Parasitol 2010; 26: 11-15.
128. Carvalho LJM. Murine cerebral malaria: how far from human cerebral malaria? Trends Parasitol 2010; 26: 271-272.
129. Renia L, Gruner AC & Snounou G. Cerebral malaria: in praise of epistemes. Trends Parasitol 2010; 26: 275-277.
130. Renia L, Potter SM, Mauduit M, et al. Pathogenic T cells in cerebral malaria. Int J Parasitol 2006; 36: 547-554.
131. Engwerda C, Belnoue E, Gruner AC & Renia L. Experimental models of cerebral malaria. Curr Top Microbiol Immunol 2005; 297: 103-143.
132. Fonager J, Pasini EM, Braks JA, et al. Reduced CD36-dependent tissue sequestration of Plasmodium-infected erythrocytes is detrimental to malaria parasite growth in vivo. J Exp Med 2012; 209: 93-107.
133. Cabrales P, Zanini GM, Meays D, Frangos JA & Carvalho LJM. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol 2010; 176: 1306-1315.
134. Fauconnier M, Palomo J, Bourigault ML, et al. IL-12Rbeta2 is essential for the development of experimental cerebral malaria. J Immunol 2012; 188: 1905-1914.
135. Franke-Fayard B, Janse CJ, Cunha-Rodrigues M, et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci USA 2005; 102: 11468-11473.
136. Suidan GL, McDole JR, Chen Y, Pirko I & Johnson AJ. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS ONE 2008; 3: e3037.
137. von zur Muhlen C, Peter K, Ali ZA, et al. Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa. J Vasc Res 2009; 46: 6-14.
138. Lacerda-Queiroz N, Rodrigues DH, Vilela MC, et al. Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice. Exp Parasitol 2010; 125: 271-278.
139. Cho S, Kim S, Kim Y & Park Y. Optical imaging techniques for the study of malaria. Trends Biotechnol 2012; 30: 71-79.
140. Braks J, Aime E, Spaccapelo R, Klop O, Janse CJ & Franke-Fayard B. Bioluminescence imaging of P. berghei schizont sequestration in rodents. Methods Mol Biol 2013; 923: 353-368.
141. Amino R, Menard R & Frischknecht F. In vivo imaging of malaria parasites-recent advances and future directions. Curr Opin Microbiol 2005; 8: 407-414.
142. Grutzendler J, Yang G, Pan F, Parkhurst CN & Gan WB. Transcranial two-photon imaging of the living mouse brain. Cold Spring Harb Protoc 2011; 2011: 1080-1088.
143. Yang G, Pan F, Parkhurst CN, Grutzendler J & Gan WB. Thinned-skull cranial window technique for long-term imaging of the cortex in live mice. Nat Protoc 2010; 5: 201-208.
144. Ortolano F, Maffia P, Dever G, et al. Advances in imaging of new targets for pharmacological intervention in stroke: real-time tracking of T-cells in the ischaemic brain. Br J Pharmacol 2009; 159: 808-811.
145. Villringer A, Haberl RL, Dirnagl U, Anneser F, Verst M & Einhaupl KM. Confocal laser microscopy to study microcirculation on the rat brain surface in vivo. Brain Res 1989; 504: 159-160.
146. Mostany R & Portera-Cailliau C. A craniotomy surgery procedure for chronic brain imaging. J Vis Exp 2008; 12: e680 10.3791/680. doi: 10.3791/680.
147. Holtmaat A, Bonhoeffer T, Chow DK, et al. Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window. Nat Protoc 2009; 4: 1128-1144.
148. Lacerda-Queiroz N, Lima OC, Carneiro CM, et al. Plasmodium berghei NK65 induces cerebral leukocyte recruitment in vivo: an intravital microscopic study. Acta Trop 2011; 120: 31-39.
149. Rodrigues-Duarte L, de Moraes LV, Barboza R, et al. Distinct placental malaria pathology caused by different Plasmodium berghei lines that fail to induce cerebral malaria in the C57BL/6 mouse. Malar J 2012; 11: 231.
150. Lou J, Lucas R & Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev 2001; 14: 810-820.
151. Nagao E, Arie T, Dorward DW, Fairhurst RM & Dvorak JA. The avian malaria parasite Plasmodium gallinaceum causes marked structural changes on the surface of its host erythrocyte. J Struct Biol 2008; 162: 460-467.
152. Aikawa M, Hsieh CL & Miller LH. Ultrastructural changes of the erythrocyte membrane in ovale-type malarial parasites. J Parasitol 1977; 63: 152-154.
153. Cromer D, Evans KJ, Schofield L & Davenport MP. Preferential invasion of reticulocytes during late-stage Plasmodium berghei infection accounts for reduced circulating reticulocyte levels. Int J Parasitol 2006; 36: 1389-1397.
154. Zuckerman A & Yoeli M. Age and sex as factors influencing Plasmodium berghei infections in intact and splenectomized rats. J Infect Dis 1954; 94: 225-236.
155. Singer I. The effect of x irradiation on infections with Plasmodium berghei in the white mouse. J Infect Dis 1953; 92: 97-104.
156. McNally J, O'Donovan SM & Dalton JP. Plasmodium berghei and Plasmodium chabaudi chabaudi: development of simple in vitro erythrocyte invasion assays. Parasitology 1992; 105(Pt 3): 355-362.
157. Clark IA & Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 1988; 70: 99-103.
158. Barnwell JW & Galinski MR. Plasmodium vivax: a glimpse into the unique and shared biology of the merozoite. Ann Trop Med Parasitol 1995; 89: 113-120.
159. Cox FEG. Major animal models in malaria research: rodent. In Wernsdorfer WH & McGregor I (eds): Malaria Principles and Practice of Malariology. Edinburgh, UK, Churchill Livingstone, 1988: 1503-1543.
160. Yoeli M, Hargreaves B, Carter R & Walliker D. Sudden increase in virulence in a strain of Plasmodium berghei yoelii. Ann Trop Med Parasitol 1975; 69: 173-178.
161. Bungener W. Virulence of Plasmodium yoelii line YM is caused by altered preference for parasitized and unparasitized immature and mature erythrocytes. Trop Med Parasitol 1985; 36: 43-45.
162. Hegner R. Relative frequency of ring-stage plasmodia in reticulocytes and mature erythrocytes in man and monkey. Am J Hyg 1938; 27: 690-718.
163. Cooke BM, Mohandas N & Coppel RL. Malaria and the red blood cell membrane. Semin Hematol 2004; 41: 173-188.
164. Persons EL. Studies on red cell diameter: III. The relative diameter of immature (reticulocytes) and adult red blood cells in health and anemia, especially in pernicious anemia. J Clin Invest 1929; 7: 615-629.
165. Newton CR, Kirkham FJ, Winstanley PA, et al. Intracranial pressure in African children with cerebral malaria. Lancet 1991; 337: 573-576.
166. Trager W. Cultivation of malaria parasites. Mol Cell Biol 1994; 45: 7-26.
167. Trager W & Jensen JB. Continuous culture of Plasmodium falciparum: its impact on malaria research. Int J Parasitol 1997; 27: 989-1006.
168. Radfar A, Mendez D, Moneriz C, et al. Synchronous culture of Plasmodium falciparum at high parasitemia levels. Nat Protoc 2009; 4: 1899-1915.
169. Trigg PI. Recent advances in malaria parasite cultivation and their application to studies on host-parasite relationships: a review. Bull World Health Organ 1985; 63: 387-398.
170. Chu YC, Chen CZ, Lee CH, Chen CW, Chang HY & Hsiue TR. Prediction of arterial blood gas values from venous blood gas values in patients with acute respiratory failure receiving mechanical ventilation. J Formos Med Assoc 2003; 102: 539-543.
171. Malatesha G, Singh NK, Bharija A, Rehani B & Goel A. Comparison of arterial and venous pH, bicarbonate, PCO2 and PO2 in initial emergency department assessment. Emerg Med J 2007; 24: 569-571.
172. Vaughan AM, Mikolajczak SA, Camargo N, et al. A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. Mol Biochem Parasitol 2012; 186: 143-147.
173. Vaughan AM, Mikolajczak SA, Wilson EM, et al. Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest 2012; 122: 3618-3628.
174. Owens T, Bechmann I & Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 2008; 67: 1113-1121.
175. Battle KE, Gething PW, Elyazar IR, et al. The global public health significance of Plasmodium vivax. Adv Parasitol 2012; 80: 1-111.
176. Posner JB, Saper CB, Schiff ND & Plum F. Multifocal, diffuse, and metabolic brain diseases causing delirium, stupor, or coma. In Posner JB, Saper CB, Schiff ND & Plum F (eds): Plum and Posner's Diagnosis of Stupo and Coma. Oxford, Oxford University Press, 2007: 179-296.
177. Kipp M & Amor S. FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination. Mult Scler 2012; 18: 258-263.
178. van Nieuw Amerongen GP & van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperpermeability and barrier function. Vascul Pharmacol 2003; 39: 257-272.
179. Mehta D & Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86: 279-367.
180. Hla T & Brinkmann V. Sphingosine 1-phosphate (S1P): physiology and the effects of S1P receptor modulation. Neurology 2011; 76: S3-S8.
181. Chun J & Hartung HP. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol 2010; 33: 91-101.
182. Dev KK, Mullershausen F, Mattes H, et al. Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis. Pharmacol Ther 2008; 117: 77-93.
183. Lee MJ, Thangada S, Claffey KP, et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999; 99: 301-312.
184. Grau GE, Pointaire P, Piguet PF, et al. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol 1991; 21: 2265-2267.
185. Brinkmann V, Billich A, Baumruker T, et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 2010; 9: 883-897.
186. Taylor PA, Ehrhardt MJ, Lees CJ, et al. Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood 2007; 110: 3480-3488.
187. Finney CA, Hawkes CA, Kain DC, et al. S1P is associated with protection in human and experimental cerebral malaria. Mol Med 2011; 17: 717-725.
188. Lovegrove FE, Tangpukdee N, Opoka RO, et al. Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS ONE 2009; 4: e4912.
189. Conroy AL, Glover SJ, Hawkes M, et al. Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study. Crit Care Med 2012; 40: 952-959.
190. Conroy AL, Lafferty EI, Lovegrove FE, et al. Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria. Malar J 2009; 8: 295.
191. Jain V, Lucchi NW, Wilson NO, et al. Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India. Malar J 2011; 10: 383.
192. Jambou R, Combes V, Jambou MJ, Weksler BB, Couraud PO & Grau GE. Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog 2010; 6: e1001021.
193. Zougbede S, Miller F, Ravassard P, et al. Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity. J Cereb Blood Flow Metab 2011; 31: 514-526.
194. Posner JB, Saper CB, Schiff ND & Plum F. Prognosis in coma and related disorders of consciousness, mechanisms underlying outcomes, and ethical considerations. In Posner JB, Saper CB, Schiff ND & Plum F (eds): Plum and Posner's Diagnosis of Stupo and Coma. Oxford: Oxford University Press, 2007: 341-385.
195. Manning L, Laman M, Rosanas-Urgell A, et al. Severe anemia in Papua New Guinean children from a malaria-endemic area: a case-control etiologic study. PLoS Negl Trop Dis 2012; 6: e1972.